A Growing Threat Sees Growing Support

Since 2003, November has been a month of awareness and fundraising for prostate cancer thanks to the charity movement Movember. Originating in Australia before branching out to the UK, the charity shows a great awareness of the dangers that prostate cancer poses to males of all ages.

In the UK, prostate cancer remains the most common type of cancer with 25% of new cases in men being diagnosed as prostate, or some 44,000 cases this year. This number is also predicted to rise over the coming years and decade due to the increasing and aging population. It is in fact already becoming the third biggest cancer killer in the UK, over taking breast cancer in the process. This simply highlights the need for charities like Movember to bring awareness to this disease and make sure the momentum is kept up in the fight against it.

Like Movember highlights this issue, so too does the European Oncology Convention. One of the focus areas of the event is on genitourinary cancer, with a complete seminar theatre dedicated to the topic. This theatre will see some of the sharpest minds in the industry contributing to the education stream available at the event, and it will be here that visitors can find opportunities to hear from the likes of Arie Parnham, who is just one of three doctors in the country capable of managing penile cancer in the NHS. Based at The Christie NHS Foundation Trust, Arie Parnham will take a detailed look into the current advances in penile cancer. Whilst not as common as prostate cancer, the elderly generation are far more at risk of this disease, and with an aging population this risk will only increase.  

Dr Simon Crabb is a genitourinary cancer specialist at the University Hospital Southampton and also an Associate Professor in Medical Oncology at the University of Southampton. With the increasing number of cases each year, and prostate cancer killing 10,000 men a year, this seminar will explore the novel ways in which our doctors are able to combat this growing illness.

The speakers won’t be the only way with which the European Oncology Convention will be highlighting this growing issue, as Prostate Cancer UK will be exhibiting at the event. This will provide insight into why prostate cancer is on its way to becoming the most overall common cancer in the UK by 2030 and also the steps for prevention, diagnosis capabilities, treatment and the care available. Prostate Cancer UK will be one of the exhibitors able to expertly map the patient journey to highlight improvement areas and where funding can help. Donating to charities like Movember and Prostate Cancer UK will mean that funding will find its way to the essential research into this disease.

There is still more to be announced for the dedicated GU theatre, and the best way to remain up to date whilst also securing your attendance to the European Oncology Convention is to register for a free ticket by following the link at the top of the page.

The event takes place at the NEC in Birmingham on the 26th and 27th March, running alongside the European Neurology Convention, Medical Imaging Convention, Dementia Care & Nursing Home Expo, Smart Home Expo and Naidex.

If you supply products and services that aid in the battle against prostate cancer, please do not hesitate to get in contact with Nick Woore on 0117 929 6097 or at nick.woore@prysmgroup.co.uk